Not yet recruiting
Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma
NCT07379489
- Conditions
- Adjuvant Therapy, Disease Attributes, HCC, +4 more
- Locations
-
Not specified
Clinical trial condition
HCC
Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.
98 public trials
29 recruiting studies
HCC trial results
NCT07353333
- Conditions
- HCC, SPECT-CT
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
NCT07350824
- Conditions
- Disease Attributes, HCC, Minimal Residual Disease, +6 more
- Locations
-
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular
NCT07352007
- Conditions
- HCC
- Locations
-
- ShandongShandong Cancer Hospital and Institute Jinan, Shandong, China
Not yet recruiting
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
NCT07350070
- Conditions
- Digestive System Diseases, Fibrosis, HCC, +6 more
- Locations
-
- Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology Fuzhou, Fujian, China
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
- Hubei Province Tahe Hospital Taihe, Hubei, China
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma
NCT07340502
- Conditions
- HCC
- Locations
-
Not specified
NCT07119931
- Conditions
- HCC
- Locations
-
Not specified
Not yet recruiting
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286
- Conditions
- HBV, HCC
- Locations
-
- Qitaihe Infectious Disease Hospital Heilongjiang, China
- Yizheng People's Hospital Yizheng, Jiangsu, China
- Changle County People's Hospital Changle, Shandong, China
- Juxian People's Hospital Junxian, Shandong, China
Not yet recruiting
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
NCT06984718
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified
Not yet recruiting
A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
NCT06584071
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, HCC, +5 more
- Locations
-
Not specified